Vivo Ventures Vi, Llc - Net Worth and Insider Trading

Vivo Ventures Vi, Llc Net Worth

The estimated net worth of Vivo Ventures Vi, Llc is at least $661,613 dollars as of 2024-11-10. Vivo Ventures Vi, Llc is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 30,405 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $661,613. Details can be seen in Vivo Ventures Vi, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivo Ventures Vi, Llc has not made any transactions after 2013-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Vivo Ventures Vi, Llc

To

Vivo Ventures Vi, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures Vi, Llc owns 3 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , Sagent Pharmaceuticals Inc (SGNT) , and KalVista Pharmaceuticals Inc (KALV) .

Click here to see the complete history of Vivo Ventures Vi, Llc’s form 4 insider trades.

Insider Ownership Summary of Vivo Ventures Vi, Llc

Ticker Comapny Transaction Date Type of Owner
EIGRQ Eiger BioPharmaceuticals Inc 2016-03-22 10 percent owner
SGNT Sagent Pharmaceuticals Inc 2016-04-21 10 percent owner
KALV KalVista Pharmaceuticals Inc 2015-04-08 10 percent owner

Vivo Ventures Vi, Llc Latest Holdings Summary

Vivo Ventures Vi, Llc currently owns a total of 1 stock. Vivo Ventures Vi, Llc owns 30,405 shares of Sagent Pharmaceuticals Inc (SGNT) as of September 16, 2013, with a value of $661,613.

Latest Holdings of Vivo Ventures Vi, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGNT Sagent Pharmaceuticals Inc 2013-09-16 30,405 21.76 661,613

Holding Weightings of Vivo Ventures Vi, Llc


Vivo Ventures Vi, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Vivo Ventures Vi, Llc has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 622,700 shares on September 16, 2013, which brought Vivo Ventures Vi, Llc around $13 Million.

Insider Trading History of Vivo Ventures Vi, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vivo Ventures Vi, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Ventures Vi, Llc Ownership Network

Ownership Network List of Vivo Ventures Vi, Llc

No Data

Ownership Network Relation of Vivo Ventures Vi, Llc

Insider Network Chart

Vivo Ventures Vi, Llc Owned Company Details

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Vivo Ventures Vi, Llc is the 10 percent owner of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Vivo Ventures Vi, Llc made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

Vivo Ventures Vi, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Ventures Vi, Llc. You might contact Vivo Ventures Vi, Llc via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.